| Product Code: ETC12772889 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Non-Small Cell Lung Cancer Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Non-Small Cell Lung Cancer Market - Industry Life Cycle |
3.4 Mexico Non-Small Cell Lung Cancer Market - Porter's Five Forces |
3.5 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Mexico Non-Small Cell Lung Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Mexico |
4.2.2 Technological advancements in lung cancer treatment |
4.2.3 Growing awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 High cost of lung cancer treatments |
4.3.2 Limited access to advanced healthcare facilities in certain regions of Mexico |
4.3.3 Stringent regulatory requirements for drug approvals |
5 Mexico Non-Small Cell Lung Cancer Market Trends |
6 Mexico Non-Small Cell Lung Cancer Market, By Types |
6.1 Mexico Non-Small Cell Lung Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021 - 2031F |
6.1.5 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031F |
6.1.6 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Mexico Non-Small Cell Lung Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 Mexico Non-Small Cell Lung Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4 Mexico Non-Small Cell Lung Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.4.3 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Tumor Management, 2021 - 2031F |
6.4.4 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4.5 Mexico Non-Small Cell Lung Cancer Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
7 Mexico Non-Small Cell Lung Cancer Market Import-Export Trade Statistics |
7.1 Mexico Non-Small Cell Lung Cancer Market Export to Major Countries |
7.2 Mexico Non-Small Cell Lung Cancer Market Imports from Major Countries |
8 Mexico Non-Small Cell Lung Cancer Market Key Performance Indicators |
8.1 Patient survival rates after treatment |
8.2 Adoption rate of innovative lung cancer therapies |
8.3 Rate of participation in lung cancer screening programs |
8.4 Availability and utilization of supportive care services |
8.5 Number of clinical trials for new lung cancer treatments in Mexico |
9 Mexico Non-Small Cell Lung Cancer Market - Opportunity Assessment |
9.1 Mexico Non-Small Cell Lung Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Mexico Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Mexico Non-Small Cell Lung Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Mexico Non-Small Cell Lung Cancer Market - Competitive Landscape |
10.1 Mexico Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024 |
10.2 Mexico Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here